-
Innovation Ranking
NewInnovation Ranking – Incitec Pivot Ltd
Incitec Pivot Ltd (IPL) is an industrial chemical company that manufactures and sells fertilizers, chemicals, and explosives. The company's products include nitrogen and phosphorus fertilizers, nitrogen-related industrial and specialty chemicals, and ammonium nitrate-based explosives. IPL also provides explosive-related products and services. Its products find application in the mining and farming businesses, and support infrastructure, food, and energy sectors. It has joint venture operations in US, Canada, Mexico, France, Nigeria, New Caledonia, Mongolia, South Africa and Australia. The company has manufacturing...
-
Product Insights
Pivot Energy Illinois Solar PV Park, US
Pivot Energy Illinois Solar PV Park is proposed to be built in Illinois, United States. The project is at the permitting stage. Empower your strategies with our Pivot Energy Illinois Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
NewClinical Trials Scorecard for Investigations in 2023
This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023.
-
Sector Analysis
NewBulgaria Cards and Payments – Opportunities and Risks to 2028
Bulgaria Cards and Payments Market Report Overview The annual value of card transactions in the Bulgaria cards and payments market was $17.3 billion in 2023. The value will grow at a CAGR of more than 12% during 2024-2028. Cash continues to play a pivotal role in Bulgaria. However, the central bank and government are introducing payment regulations, improving payment-acceptance infrastructure, and mandating POS terminal installation in the country to promote electronic payments. Bulgaria Card Transactions Outlook, 2023-2028 ($ Billion) Buy...
-
Product Insights
Likelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
Likelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...
-
Government & Regulation
NewCanada Mining Fiscal Landscape – Regulations Governance and Sustainability
Canada Mining Fiscal Landscape Report Overview Canada is one of the largest mineral producers globally and produces more than 60 metals and minerals, including potash, uranium, platinum, indium, and aluminium, among others. Furthermore, Canada is one of the world's largest bauxite importers. Canada’s mining industry is governed by different departments and agencies under provincial governments. However, in cases such as mineral activities on federal lands and offshore areas, as well as the usage of uranium as a nuclear fuel, a...
-
Product Insights
Likelihood of Approval Analysis for X Chromosome Disorders
Overview How likely is it that the drugs in X Chromosome Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. X Chromosome Disorders Overview X chromosome disorders, also termed X-linked disorders,...
-
Product Insights
Likelihood of Approval Analysis for Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Overview How likely is it that the drugs in Skin And Skin Structure Infections (SSSI) Caused By Bacteria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Skin And Skin Structure Infections...
-
Thematic Analysis
Rare Disease ​Pipeline Analysis ​Landscape, 2023
This report investigates the Rare Disease ​Pipeline Analysis ​Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize these trends within your sector.